01 1DAPAGLIFLOZIN INTERMEDIATE (DP3)
02 1EMPAGLIFLOZIN ADVANCED INTERMIDIATE (EP2)
03 1FOR NATURAL LATEX SHEETING-
04 1L-1/ATV-1/(4R-cis)-1,1-DIMETHYLETHYL-6-[2-[2-(4-FLUOROPHENYL)-5-(1-ISOPROPYL)-3-PHENYL-4-[(PHENYLAMINO) CARBONYL]-1H-pyrrol-1-yl] ETHYL]-2,2-DIMETHYL-1,3-DIOXANE-4-ACETATE
05 1ROSUVASTATIN CALCIUM INTERMEDIATE (R-2)
06 1ROSUVASTATIN CALCIUM INTERMEDIATE (R-2) (PROCESS 2)
01 1HYGENIC CORP
02 5ZHEJIANG HONGYUAN PHARMACEUTICAL CO LTD
01 4China
02 1U.S.A
03 1Blank
01 5Active
02 1Inactive
01 6Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39284
Submission : 2023-12-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38905
Submission : 2023-09-27
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39218
Submission : 2023-12-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42171
Submission : 2025-12-31
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4511
Submission : 1982-04-20
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38753
Submission : 2023-08-29
Status : Active
Type : II
